{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:13Z","timestamp":1789473913435,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exphem.2026.105472","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:11:03Z","timestamp":1783120263000},"page":"105472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9432-224X","authenticated-orcid":false,"given":"Alessandro","family":"Lagan\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6616-5884","authenticated-orcid":false,"given":"Giovanni","family":"Iaquinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina","family":"Santopietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7267-3281","authenticated-orcid":false,"given":"Giovanni","family":"Luzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ragazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0272-2843","authenticated-orcid":false,"given":"Silvia","family":"Angeloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-2089","authenticated-orcid":false,"given":"Chiara","family":"Cerroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Leonetti Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Tatarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5228-6491","authenticated-orcid":false,"given":"Elisabetta","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata Monika","family":"Trawinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Celesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Caravita Di Toritto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Grammatico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105472_bib0001","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1073\/pnas.89.12.5640","article-title":"Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily","volume":"89","author":"Vigon","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2026.105472_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8722-6-11","article-title":"Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases","volume":"6","author":"He","year":"2013","journal-title":"J Hematol Oncol."},{"key":"10.1016\/j.exphem.2026.105472_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/geno.1994.1120","article-title":"Structure and transcription of the human c-mpl gene (MPL)","volume":"20","author":"Mignotte","year":"1994","journal-title":"Genomics."},{"key":"10.1016\/j.exphem.2026.105472_bib0004","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.94.6.2350","article-title":"Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain","volume":"94","author":"Drachman","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2026.105472_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2024.100018","article-title":"Structural basis of MPL activation by thrombopoietin","volume":"1","author":"Mafi","year":"2024","journal-title":"Blood Vessel Thromb Hemost."},{"key":"10.1016\/j.exphem.2026.105472_bib0006","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia."},{"key":"10.1016\/j.exphem.2026.105472_bib0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2008-01-131664","article-title":"MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort","volume":"112","author":"Beer","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105472_bib0008","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jmoldx.2013.07.006","article-title":"Detection of MPL mutations by a novel allele-specific PCR-based strategy","volume":"15","author":"Furtado","year":"2013","journal-title":"J Mol Diagn."},{"key":"10.1016\/j.exphem.2026.105472_bib0009","article-title":"Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.exphem.2026.105472_bib0010","article-title":"A novel complex mutation affecting two codons in the exon 10 hotspot region of the MPL gene","volume":"74","author":"Iaquinta","year":"2026","journal-title":"Curr Res Transl Med."},{"key":"10.1016\/j.exphem.2026.105472_bib0011","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1002\/cam4.2387","article-title":"Two activating mutations of MPL in triple-negative myeloproliferative neoplasms","volume":"8","author":"Xie","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.exphem.2026.105472_bib0012","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood.2019002561","article-title":"Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning","volume":"135","author":"Bridgford","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105472_bib0013","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2008-04-149047","article-title":"The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity","volume":"114","author":"Ding","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105472_bib0014","article-title":"Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia","volume":"2013","author":"Morrell","year":"2013","journal-title":"Case Rep Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0015","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.exphem.2008.06.006","article-title":"Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray","volume":"36","author":"Kawamata","year":"2008","journal-title":"Exp Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0016","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ajh.23138","article-title":"A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia","volume":"87","author":"Lambert","year":"2012","journal-title":"Am J Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0017","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med."},{"key":"10.1016\/j.exphem.2026.105472_bib0018","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.exphem.2026.105472_bib0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn."},{"key":"10.1016\/j.exphem.2026.105472_bib0020","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.exphem.2026.105472_bib0021","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","article-title":"Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms","volume":"127","author":"Milosevic Feenstra","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105472_bib0022","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1073\/pnas.1407688111","article-title":"Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers","volume":"111","author":"Xu","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2026.105472_bib0023","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1038\/s41375-021-01228-y","article-title":"Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin","volume":"35","author":"Batta","year":"2021","journal-title":"Leukemia."},{"key":"10.1016\/j.exphem.2026.105472_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2016.05.010","article-title":"Concurrent MPL W515L and Y591D mutations in a patient with myelofibrosis","volume":"60","author":"Rashidi","year":"2016","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.exphem.2026.105472_bib0025","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.3324\/haematol.2020.250969","article-title":"Clinical acceleration of JAK2 p.V617F driven myeloproliferative disease due to a new uncommon homozygous MPL p.Y591D mutation","volume":"105","author":"Ong","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2026.105472_bib0026","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.exphem.2014.02.007","article-title":"Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling","volume":"42","author":"Sangkhae","year":"2014","journal-title":"Exp Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0027","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1182\/blood-2008-01-134049","article-title":"YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation","volume":"112","author":"Hitchcock","year":"2008","journal-title":"Blood."},{"issue":"Suppl 2","key":"10.1016\/j.exphem.2026.105472_bib0028","first-page":"S160","article-title":"Incidence of non-canonical mutations of JAK2 and MPL in chronic myeloproliferative neoplasms","volume":"105","author":"Fiaccabrino","year":"2020","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"10.1016\/j.exphem.2026.105472_bib0029","first-page":"573","article-title":"Clinicopathologic and molecular characteristics of myeloid neoplasms with non-canonical MPL mutations","volume":"31","author":"Thakral","year":"2018","journal-title":"Mod Pathol."},{"key":"10.1016\/j.exphem.2026.105472_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2015-07-661983","article-title":"Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients","volume":"127","author":"Cabagnols","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105472_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.75","article-title":"Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing","volume":"6","author":"Angona","year":"2016","journal-title":"Blood Cancer J."},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2026.105472_bib0032","first-page":"634A","article-title":"Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2\/calr mutations","volume":"146","author":"Chen","year":"2025","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105472_bib0033","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.3390\/cancers15153904","article-title":"Clinical characteristics and outcomes of patients with primary and secondary myelofibrosis according to the genomic classification using targeted next-generation sequencing","volume":"15","author":"Garrote","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.exphem.2026.105472_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.610525","article-title":"Integration Analysis of JAK2 or RUNX1 mutation with bone marrow blast can improve risk stratification in the patients with lower risk myelodysplastic syndrome","volume":"10","author":"Fang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.exphem.2026.105472_bib0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.72.121801.161800","article-title":"Signals for sorting of transmembrane proteins to endosomes and lysosomes","volume":"72","author":"Bonifacino","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2026.105472_bib0036","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2008-10-183558","article-title":"Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor","volume":"115","author":"Pecquet","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105472_bib0037","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pathol.2021.01.003","article-title":"Myeloid somatic mutation panel testing in myeloproliferative neoplasms","volume":"53","author":"Ross","year":"2021","journal-title":"Pathology."},{"key":"10.1016\/j.exphem.2026.105472_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2025.105333","article-title":"Germline heterozygous SH2B3 p.Glu78Lys variant: a three-patient case series with myeloproliferative neoplasms","volume":"154","author":"Iaquinta","year":"2026","journal-title":"Exp Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149587","article-title":"Variants of uncertain significance: at the crux of diagnostic odyssey","volume":"962","author":"Zawar","year":"2025","journal-title":"Gene."},{"key":"10.1016\/j.exphem.2026.105472_bib0040","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajh.70098","article-title":"Prevalence of concurrent (double-positive) JAK2, CALR, or MPL mutations and corresponding clinicopathologic features: analysis of 21556 Mayo Clinic NGS studies including 2651 informative cases","volume":"100","author":"He","year":"2025","journal-title":"Am J Hematol."},{"key":"10.1016\/j.exphem.2026.105472_bib0041","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/gim.2017.210","article-title":"Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework","volume":"20","author":"Tavtigian","year":"2018","journal-title":"Genet Med."}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26001050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26001050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:33:33Z","timestamp":1789472013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S0301472X26001050"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105472","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105472"}}